Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer

NCT03839940 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Severe lack of accrual

Conditions

Malignant Neoplasm

Interventions

DRUG: Dexamethasone
OTHER: Placebo
OTHER: Questionnaire
OTHER: Quality-of-Life Assessment
DRUG: Everolimus

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]